The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how popular or effective it will be.

Care payment models CMS introduced in 2025 include six new initiatives targeting drug pricing, chronic disease, and specialty care payments.

The Centers for Medicare & Medicaid Services (CMS) has withdrawn its approval of the Board of Certification/Accreditation (BOC) as an accreditation organization for suppliers of durable medical equipm

CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care by tying payments to patient outcomes and encouraging tech-enabled, preventive care.

The Trump administration has revealed what comes next when the ACO REACH model concludes at the end of 2026. | The Trump administration has revealed what comes next when the ACO REACH model concludes at the end of 2026.

On Friday, December 19, the Centers for Medicare & Medicaid Services (CMS) announced two new pilot programs aimed at reducing Medicare spending on prescription drugs and reducing beneficiaries’ out-of-pocket costs.